Qnexa category
Mango Seeds and Slimming Benefits
Posted: Wednesday, 3 August, 2011 | Categories: slimming pills, weight loss, qnexa
One of the most popular products for slimming down at the moment is the African mango and there is proof of its success following two studies carried out in Cameroon. The seeds were extracted and the effects on weight loss and blood fat levels were assessed over a period of 4 weeks and compared to a placebo group.The results proved that the group lost on average 5.3% of their original body weight versus the placebo group who only lost 1.3%. Substantial decreases in blood cholesterol were observed in addition.
The seeds contain soluble fibre and delay the digestion process resulting in a slower passing of glucose into the blood stream. The ingredients of this herbal treatment however are contained in many herbal weight loss treatments that have not been tested by regulators. The product is therefore not recommended for consumption as of yet. Still Xenical is the only weight loss drug licensed for use in the EU.
We await news of the hopeful qnexa, Vivus’ promising weight loss treatment.
New Slimming Pill in the Pipeline
Posted: Wednesday, 7 October, 2009 | Categories: slimming pills, weight loss, qnexa, diet pill, slimming pill, Qnexa
Pharmaceutical experts and doctors are getting excited about promising new results released by the pharmaceutical firm Vivus into clinical trials of their new diet pill Qnexa.
The trials have indicated that the pill could be more effective than any pill currently on the market, with patients taking the high dose losing almost 15% of their body weight and those on the lower dose losing 8% of their body weight. The users of the diet pill also saw their blood pressure drop, the health of their heart improve and their chances of developing type 2 diabetes fall.
The pill combines two medications that have already been separately trialled. The first, phentermine, was a popular weight loss drug until 10 years ago when it fell out of favour with doctors due to safety concerns. The other is an epilepsy medication called Topiramate which has been shown to promote weight loss.
3,750 obese people took part in the trials and over the 53-week trial period the average amount lost was 14.7% of each patient’s body fat. The results have been described by the lead scientist on the trial, Dr Louis Aronne of the New York Presbytarian Hospital, as “spectacular.”
He went on to say that the results were as good as those experienced by patients who have had gastric bands fitted . He then added that those battling the obesity crisis were “in desperate need of more options and effective drugs to treat obesity and the results of this trial were extremely encouraging.”